Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
PUT
Tandem Diabetes Care
TNDM
$1.09B
| $302K | ﹤0.01% |
20,000
-21,800
| -52% | -$381K |
|
3452
Northeast Community Bancorp
NECB
$369M
| $301K | ﹤0.01% |
10,846
-1,385
| -11% | -$34.4K |
|
3453
FIGS
FIGS
$2.23B
| $300K | ﹤0.01% |
29,358
+4,225
| +17% | +$55.5K |
|
3454
PRA Group
PRAA
$777M
| $300K | ﹤0.01% |
15,812
+4,520
| +40% | +$80.3K |
|
3455
ACV Auctions
ACVA
$1.78B
| $298K | ﹤0.01% |
41,397
+2,318
| +6% | +$13.1K |
|
3456
Matrix Service
MTRX
$276M
| $297K | ﹤0.01% |
21,704
-4,510
| -17% | -$58.1K |
|
3457
Limbach Holdings
LMB
$614M
| $297K | ﹤0.01% |
3,858
-213
| -5% | -$17.7K |
|
3458
Ginkgo Bioworks
DNA
$718M
| $297K | ﹤0.01% |
29,966
+21,988
| +276% | +$184K |
|
|
NB
3459
NioCorp Developments
NB
$515M
| $296K | ﹤0.01% |
61,383
-47,766
| -44% | -$261K |
|
3460
Third Coast Bancshares
TCBX
$720M
| $296K | ﹤0.01% |
7,321
-1,765
| -19% | -$68.8K |
|
|
ORC
3461
Orchid Island Capital
ORC
$1.13B
| $296K | ﹤0.01% |
42,416
-95,150
| -69% | -$656K |
|
3462
Concentrix
CNXC
$1.65B
| $295K | ﹤0.01% |
13,186
-1,176
| -8% | -$30.7K |
|
3463
Grocery Outlet
GO
$1.1B
| $294K | ﹤0.01% |
29,490
-283,126
| -91% | -$2.33M |
|
3464
Evertec
EVTC
$1.68B
| $291K | ﹤0.01% |
10,467
-45,358
| -81% | -$1.21M |
|
|
EFC
3465
Ellington Financial
EFC
$1.59B
| $290K | ﹤0.01% |
21,331
-86,775
| -80% | -$1.15M |
|
|
LBRX
3466
LB Pharmaceuticals
LBRX
$1.2B
| $290K | ﹤0.01% |
8,928
+4,398
| +97% | +$129K |
|
|
AEBI
3467
Aebi Schmidt Holding AG
AEBI
$854M
| $290K | ﹤0.01% |
23,088
-40,934
| -64% | -$483K |
|
3468
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.8B
| $288K | ﹤0.01% |
3,275
| – | – |
|
|
TIC
3469
TIC Solutions Inc
TIC
$1.94B
| $288K | ﹤0.01% |
35,552
-2,508
| -7% | -$21.2K |
|
3470
Westrock Coffee
WEST
$790M
| $288K | ﹤0.01% |
35,454
+10,699
| +43% | +$76.8K |
|
3471
Hanover Bancorp
HNVR
$187M
| $286K | ﹤0.01% |
12,268
-326
| -3% | -$7.49K |
|
|
SION
3472
Sionna Therapeutics
SION
$236M
| $286K | ﹤0.01% |
6,495
-11,890
| -65% | -$476K |
|
3473
Gencor Industries
GENC
$256M
| $285K | ﹤0.01% |
19,129
-819
| -4% | -$12.1K |
|
3474
Myriad Genetics
MYGN
$399M
| $285K | ﹤0.01% |
49,867
-16,933
| -25% | -$76.9K |
|
3475
Information Services Group
III
$255M
| $285K | ﹤0.01% |
69,263
-1,303
| -2% | -$5.45K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.